PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy. (Q44585456)
Jump to navigation
Jump to search
scientific article published on 29 June 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy. |
scientific article published on 29 June 2012 |
Statements
PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy (English)
Mattia Barbareschi
Lucia Veronica Cuorvo
Salvatore Girlando
Emma Bragantini
Elena Leonardi
Antonella Ferro
Alessia Caldara
Renza Triolo
Chiara Cantaloni
Nicola Decarli
Enzo Galligioni
Paolo Dalla Palma
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference